Custom Deslorelin CAS 57773-65-6 - China Suppliers & Factory for Synthetic GnRH Analog and Hormonal Regulation Manufacturers, Service
Deslorelin is a powerful synthetic analog of gonadotropin-releasing hormone (GnRH), exhibiting a potency that is approximately 30–150 times greater than that of natural GnRH. As a leading GnRH agonist, Deslorelin initially stimulates the pituitary gland, resulting in a temporary surge of gonadotropins, known as the flare-up effect. However, with continued use, it promotes pituitary desensitization and downregulation of GnRH receptors, effectively inhibiting the secretion of key gonadotropins such as LH and FSH. This process ultimately leads to a reduction in the production of sex steroid hormones, Our Deslorelin is sourced from trusted suppliers in China, ensuring quality and compliance with industry standards. As an established factory, we prioritize the production of top-tier pharmaceutical products. Choose our Deslorelin for reliable performance and effective hormone regulation
Deslorelin is a synthetic gonadotropin-releasing hormone (GnRH) analog with a potency approximately 30–150 times that of natural GnRH. As a GnRH agonist, it initially and briefly stimulates the pituitary gland to release gonadotropins (the "flare-up" effect). Subsequently, through sustained agonistic action, it leads to pituitary desensitization and downregulation of GnRH receptors, thereby inhibiting the secretion of gonadotropins (LH, FSH) and ultimately suppressing the production of sex steroid hormones.
Therapeutic Areas
Veterinary application (approved)
Animal reproductive management: Widely used for reproductive suppression or estrus cycle regulation in animals such as dogs, cats, and horses, such as suppressing estrus in female dogs and controlling sexual behavior in male horses.
Treatment of animal diseases: Used to treat diseases related to sex hormones, such as prostate disease and hyperadrenocorticism in dogs.
Human medical applications (some are in the research/development stage)
Reproductive endocrine disorders: It has been studied for the treatment of hormone-dependent diseases such as precocious puberty, endometriosis, and uterine fibroids.
Prostate cancer and breast cancer: As a GnRH agonist, it can theoretically be used as adjuvant therapy for hormone-sensitive tumors, but other analogues (such as leuprorelin and goserelin) are more commonly used.
Assisted reproductive technology: pituitary downregulation in controlled ovarian stimulation (COS) cycles has been explored, but the current mainstream clinical drugs are other GnRH analogs.
Outlook & Development
Veterinary application (approved)
Animal reproductive management: Widely used for reproductive suppression or estrus cycle regulation in animals such as dogs, cats, and horses, such as suppressing estrus in female dogs and controlling sexual behavior in male horses.
Treatment of animal diseases: Used to treat diseases related to sex hormones, such as prostate disease and hyperadrenocorticism in dogs.
Human medical applications (some are in the research/development stage)
Reproductive endocrine disorders: It has been studied for the treatment of hormone-dependent diseases such as precocious puberty, endometriosis, and uterine fibroids.
Prostate cancer and breast cancer: As a GnRH agonist, it can theoretically be used as adjuvant therapy for hormone-sensitive tumors, but other analogues (such as leuprorelin and goserelin) are more commonly used.
Assisted reproductive technology: pituitary downregulation in controlled ovarian stimulation (COS) cycles has been explored, but the current mainstream clinical drugs are other GnRH analogs.
Conclusion
Deslorelin, as a GnRH agonist, is currently primarily valued in the veterinary field, particularly as a mature tool for companion animal reproductive control. In human medicine, its development has stalled due to market competition and patent issues. Future breakthroughs may depend on novel delivery systems or targeted therapy innovations, but it is unlikely to change the existing treatment landscape in the short term.
Frequently Asked Questions (FAQ)
What is Deslorelin and how does it function?
Deslorelin is a synthetic gonadotropin-releasing hormone (GnRH) analog. It acts as a GnRH agonist, initially stimulating the pituitary gland to release gonadotropins, which subsequently leads to pituitary desensitization and the suppression of sex steroid hormone production.
What are the primary veterinary uses of Deslorelin?
In veterinary medicine, it is widely approved and utilized for animal reproductive management, such as suppressing estrus in female dogs and controlling sexual behavior in male horses. It is also used to treat sex hormone-related conditions like prostate disease and hyperadrenocorticism in dogs.
Can Deslorelin be used in human medicine?
Yes, though many applications remain in the research or development stage. It has been studied for treating reproductive endocrine disorders (like endometriosis and uterine fibroids), as an adjuvant therapy for prostate and breast cancer, and for pituitary downregulation in assisted reproductive technology.
Why are other GnRH analogs preferred over Deslorelin in humans?
While Deslorelin is theoretically effective for human hormone-sensitive tumors and assisted reproduction, other GnRH analogs such as leuprorelin and goserelin are more commonly used in mainstream clinical practice due to established market presence and specific development pathways.
Why has the development of Deslorelin stalled in human medicine?
Its advancement in human medicine has largely stalled due to intense market competition from existing, well-established drugs and various patent-related issues.
What is the future outlook for Deslorelin?
Future breakthroughs for Deslorelin may depend on the development of novel delivery systems or targeted therapy innovations. However, it is unlikely to significantly alter the current treatment landscape in the short term.
Thin
